- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Essential Hypertension Complicated by Type 2 Diabetes Mellitus in China
Total 746 results
-
Beijing Dongfang Biotech Co., Ltd.Active, not recruitingDiabetes Mellitus, Type 2 | OverweightChina
-
Akros Pharma Inc.TerminatedType II Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedCardiovascular Disease | Type 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Bulgaria, Poland, Hungary, Argentina, Australia, Austria, Canada, Germany, Chile
-
Novo Nordisk A/SCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Peking UniversityUnknownObesity | Diabetes Mellitus, Type 2China
-
Yan BiNot yet recruitingDiabetic Nephropathy Type 2China
-
Shandong Provincial HospitalNot yet recruitingGlucose Metabolism Disorders | PreDiabetes | Prediabetic State | Type 2 DiabetesChina
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2China, Malaysia, Philippines
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2China, Malaysia, Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1China
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
The Affiliated Hospital of Xuzhou Medical UniversityCompletedType 2 Diabetic NephropathyChina
-
Fudan UniversityShanghai Changzheng Hospital; Shanghai 6th People's Hospital; Shanghai Minhang... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Non-alcoholic Fatty Liver DiseaseChina
-
Daping Hospital and the Research Institute of Surgery...Active, not recruitingSurgery | Esophageal Squamous Cell CarcinomaChina
-
Zhujiang HospitalCompletedChronic Obstructive Pulmonary Disease | Type 2 Diabetes MellitusChina
-
AstraZenecaCompletedDiabetes Mellitus, Non-Insulin-DependentChina
-
Novo Nordisk A/SCompleted
-
XueQing YuRecruitingDiabetes Mellitus, Type 2 | Prehypertension | Blood Pressure | Cardiovascular Risk Factor | Adverse EventChina
-
University of South ChinaRecruitingType 2 Diabetes | Coronary Artery Calcification | Vascular Calcification | Strains | microRNA | EpidemiologyChina
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
Ruijin HospitalRecruitingDiabetes Mellitus, Type 2 | Chronic Total Occlusion of Coronary ArteryChina
-
Jing TaoPeking University; University of Electronic Science and Technology of China; Xiyuan... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Cognitive DysfunctionChina
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2China
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesHong Kong, China
-
Ruijin HospitalActive, not recruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
BayerCompletedDiabetes Mellitus, Type 2China
-
Qilu Hospital of Shandong UniversityRecruitingCOVID-19 Pneumonia | Type2diabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
TakedaCompletedDiabetes Mellitus, Type 2Hong Kong, China, Taiwan
-
Peking Union Medical College HospitalHebei Dongfangyun Health Management Co.,LtdUnknownDiabetes Mellitus, Type 2 | Overweight and ObesityChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
First Affiliated Hospital of Jinan UniversityRecruitingIschemic Stroke | Type 2 Diabetes Mellitus | Transient Ischemic AttackChina
-
Ningbo No. 1 HospitalPeking UniversityCompleted
-
Shanghai Zhongshan HospitalRecruitingDiabetic Kidney Disease | Type 2 Diabetes | Cardiovascular ComplicationChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Korea, Republic of, China
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, Poland, Spain, India, Argentina, China
-
Novo Nordisk A/SCompleted
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknownDiabetes Mellitus, Type 2 | Macular EdemaChina
-
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,CompletedDiabetes Mellitus, Type 2China
-
Yanbing LiNot yet recruitingEfficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients | Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect | 128 Patients Were Randomly Assigned 1:1 | Metformin and Insulin Glargine Combined... and other conditionsChina
-
The Third Xiangya Hospital of Central South UniversityRecruitingObesity | Diabetes Mellitus, Type 2 | Bariatric Surgery Candidate | Sleeve Gastrectomy | Roux en Y Gastric BypassChina
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Type 2 DiabetesUnited States, China, Australia, India, Germany, Brazil, Argentina, Korea, Republic of, Czechia, Greece, Puerto Rico
-
Sun Yat-sen UniversityEli Lilly and Company; Ministry of Health, China; Amylin Pharmaceuticals, LLC.CompletedDiabetes Mellitus, Type 2 | Newly DiagnosedChina